@article{APM2841,
author = {Samy A. Alsirafy and Khaled M. Galal and Enas N. Abou-Elela and Noha Y. Ibrahim and Dina E. Farag and Ahmed M. Hammad},
title = {The use of opioids at the end-of-life and the survival of Egyptian palliative care patients with advanced cancer},
journal = {Annals of Palliative Medicine},
volume = {2},
number = {4},
year = {2013},
keywords = {},
abstract = {Background and aim: One of the barriers to cancer pain control and palliative care (PC) development is the misconception that the use of opioids may hasten death. This concern is exaggerated when higher doses of opioids are used at the end-of-life. The aim of this study was to investigate the relationship between survival and the dose of opioids used at the end-of-life of patients with advanced cancer in an Egyptian PC setting.
Methods: Retrospective review of the medical records of 123 patients with advanced cancer managed in an Egyptian cancer center-based palliative medicine unit (PMU). Patients were classified according to the last prescribed regular opioid dose expressed in milligrams of oral morphine equivalent (OME) per day (mg OME/24 h) into three groups: no opioid or low-dose group (},
issn = {2224-5839}, url = {https://apm.amegroups.org/article/view/2841}
}